ConductScience.org, home

Paper41870545

Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial.

Shahri B and 6 others. Naunyn Schmiedebergs Arch Pharmacol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial. Papers, record 41870545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41870545

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shahri BBahram
2Askari VRVahid Reza
3Fotouhi SSoroush
4Yadollahi AAsal
5Jarahi LLida
6Bakhoda YYaser
7Baradaran Rahimi VVafa

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
QuinolinesMajor topic
AcetatesMajor topic
C-Reactive ProteinMajor topic
Leukotriene AntagonistsMajor topic
Non-ST Elevated Myocardial InfarctionMajor topic
InflammationMajor topic
Anti-Inflammatory AgentsMajor topic
Humans
Cyclopropanes
Double-Blind Method
Sulfides
Male
Female
Biomarkers
Interleukin-6
Middle Aged
Aged
Treatment Outcome

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126948314Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain.Eur J Pharmacol2016https://conductscience.org/library/papers/26948314PubMed
240988347The Osaka Prognostic Score Predicts All-Cause in-Hospital Mortality in Patients With Non-ST-Elevation Myocardial Infarction Undergoing Early Percutaneous Coronary Intervention.Angiology2026https://conductscience.org/library/papers/40988347PubMed
332408781Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/KATP channel pathway and PPARγ receptors.Int J Neurosci2021https://conductscience.org/library/papers/32408781PubMed
421112334Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury.J Mol Cell Cardiol2011https://conductscience.org/library/papers/21112334PubMed
511167954Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.Clin Exp Allergy2001https://conductscience.org/library/papers/11167954PubMed
638337010Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction.Sci Rep2024https://conductscience.org/library/papers/38337010PubMed
732908939Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications.J Immunol Res2020https://conductscience.org/library/papers/32908939PubMed
833519477Montelukast Use Decreases Cardiovascular Events in Asthmatics.Front Pharmacol2020https://conductscience.org/library/papers/33519477PubMed
932109511Montelukast ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-α/JNK signaling pathway.Toxicol Appl Pharmacol2020https://conductscience.org/library/papers/32109511PubMed
1027432447The Role of Serum Bilirubin Levels in Predicting Troponin Positivity in Non-ST-Segment Elevation Acute Coronary Syndrome.Angiology2017https://conductscience.org/library/papers/27432447PubMed
1136394077Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.Physiol Rep2022https://conductscience.org/library/papers/36394077PubMed
1217978293Leukotrienes.N Engl J Med2007https://conductscience.org/library/papers/17978293PubMed
1339073419
Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial.
Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39073419PubMed
1436145367Montelukast and Acute Coronary Syndrome: The Endowed Drug.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36145367PubMed
1535399644Acetyl-11-Keto-β-Boswellic Acid (AKBA) Prevents Lipopolysaccharide-Induced Inflammation and Cytotoxicity on H9C2 Cells.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35399644PubMed
1626089034Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats.Hum Exp Toxicol2016https://conductscience.org/library/papers/26089034PubMed
1717646220The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics.Chest2007https://conductscience.org/library/papers/17646220PubMed
1821789470The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis.ScientificWorldJournal2011https://conductscience.org/library/papers/21789470PubMed
1931685419The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction.J Cardiothorac Vasc Anesth2020https://conductscience.org/library/papers/31685419PubMed
2029890415Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.Int Immunopharmacol2018https://conductscience.org/library/papers/29890415PubMed

See all 42 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41870545

GET https://conductscience.org/api/papers/v1/41870545/references?page=2